SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a global leader in gene editing in agriculture and the development of productivity traits in plants, today announced that the Company will report third quarter 2023 financial results on Thursday, November 9, 2023. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.
Title: Cibus, Inc. Third Quarter 2023 Results Conference Call
Event Date: Thursday, November 9, 2023
Time: 4:30 p.m. ET
Participant Numbers: +1-877-243-8548 (U.S.), +1-312-281-2974 (International)
Event Link: https://investor.cibus.com/events
For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Thursday, November 23, 2023 and can be accessed by dialing +1-844-512-2921 (U.S.), +1-412-317-6671 (International) and entering replay passcode: 22028314.
A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.
About Cibus
Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability areas for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that develops and licenses traits to leading seed companies. Cibus’ focus is developing scale, multi-crop traits in the major global crops such as canola, rice, and soybean. Traits that can make a real impact in global agricultural productivity. Cibus is the technology leader in high throughput gene editing technology with its Trait Machine™ process. It enables Cibus to develop plant traits precisely and predictably at a fraction of the time and cost of conventional breeding. Cibus has developed a pipeline of five productivity traits including important traits for pod shatter reduction, disease resistance, and weed management. Its initial traits for pod shatter reduction and weed management are developed and are in commercial collaborations with leading seed companies. Its other pipeline traits, including Sclerotinia resistance, are in advanced greenhouse and field trial stages.
Cibus Contacts:
Investor Relations
Karen Troeber
ktroeber@cibus.com
858-450-2636
Jeff Sonnek – ICR
jeff.sonnek@icrinc.com
Media Relations
Colin Sanford
colin@bioscribe.com
203-918-4347
Cibus US LLC
